Concentration‑dependent effects of paeoniflorin on proliferation and apoptosis of vascular smooth muscle cells

Guo,Yanan; Zhao,Yintao; Li,Ling; Wei,Xiaoyun; Gao,Pingjun; Zhou,Yanqiang; Liu,Yuan; Yang,Haibo

doi:10.3892/mmr.2017.7776

Concentration‑dependent effects of paeoniflorin on proliferation and apoptosis of vascular smooth muscle cells

Authors:
- Yanan Guo
- Yintao Zhao
- Ling Li
- Xiaoyun Wei
- Pingjun Gao
- Yanqiang Zhou
- Yuan Liu
- Haibo Yang
View Affiliations

Affiliations: Department of Cardiology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450000, P.R. China
Published online on: October 12, 2017 https://doi.org/10.3892/mmr.2017.7776
Pages: 9567-9572

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Vascular smooth muscle cells (VSMCs) are an important component of arterial walls, and their dysfunction may serve an important role in the development of cardiovascular diseases, including atherosclerosis and restenosis. Paeoniflorin (PF) is a principal component of the commonly used traditional Chinese medicine, peonies. To the best of our knowledge, the effects of PF on apoptosis and proliferation of VSMCs and its underlying molecular mechanisms have not been widely reported. Therefore, the present study was designed to investigated this phenomenon. VSMCs were treated with different concentrations of PF (25, 50 and 100 µg/ml) for 12, 24 or 48 h. The data demonstrated that PF treatment not only significantly decreased cell viability and DNA synthesis but also blocked G0/G1 cell cycle progression. This effect was associated with a decreased expression of cyclin D1, cyclin E, cyclin‑dependent kinase (CDK)4 and CDK2 as well as an upregulation of p21. Notably, a significant concentration‑dependent decrease in the phosphorylation of p65 and nuclear factor of κ light polypeptide gene enhancer in B‑cells inhibitor‑α (IκBα) was observed. In addition, it was demonstrated that PF promoted the apoptosis of VSMCs, which was associated with the increased expression of caspases. In conclusion, PF inhibited the proliferation of VSMCs by downregulating proteins associated with the nuclear factor‑κB signaling pathway. Furthermore, it promoted the apoptosis of VSMCs by upregulating the expression of caspases. These results may be useful in improving the understanding of the molecular mechanisms underlying the apoptotic and anti‑proliferative effects of PF on VSMCs, and facilitate the development of novel treatments for cardiovascular diseases.

View Figures

View References

1	Ross R: Cell biology of atherosclerosis. Annu Rev Physiol. 57:791–804. 1995. View Article : Google Scholar : PubMed/NCBI
2	Lusis AJ: Atherosclerosis. Nature. 407:233–241. 2000. View Article : Google Scholar : PubMed/NCBI
3	Davies MG and Hagen PO: Pathobiology of intimal hyperplasia. Br J Surg. 81:1254–1269. 1994. View Article : Google Scholar : PubMed/NCBI
4	Su G, Sun G, Liu H, Shu L, Zhang J, Guo L, Huang C and Xu J: Niacin suppresses progression of atherosclerosis by inhibiting vascular inflammation and apoptosis of vascular smooth muscle cells. Med Sci Monit. 21:4081–4089. 2015. View Article : Google Scholar : PubMed/NCBI
5	Yang J, Chen L, Ding J, Fan Z, Li S, Wu H, Zhang J, Yang C, Wang H, Zeng P and Yang J: MicroRNA-24 inhibits high glucose-induced vascular smooth muscle cell proliferation and migration by targeting HMGB1. Gene. 586:268–273. 2016. View Article : Google Scholar : PubMed/NCBI
6	Bonizzi G and Karin M: The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25:280–288. 2004. View Article : Google Scholar : PubMed/NCBI
7	Li ZW, Chu W, Hu Y, Delhase M, Deerinck T, Ellisman M, Johnson R and Karin M: The IKKbeta subunit of IkappaB kinase (IKK) is essential for nuclear factor kappaB activation and prevention of apoptosis. J Exp Med. 189:1839–1845. 1999. View Article : Google Scholar : PubMed/NCBI
8	Wu H, Zhu Z, Zhang G, Zhao L, Zhang H, Zhu D and Chai Y: Comparative pharmacokinetic study of paeoniflorin after oral administration of pure paeoniflorin, extract of Cortex Moutan and Shuang-Dan prescription to rats. J Ethnopharmacol. 125:444–449. 2009. View Article : Google Scholar : PubMed/NCBI
9	Li CR, Zhou Z, Zhu D, Sun YN, Dai JM and Wang SQ: Protective effect of paeoniflorin on irradiation-induced cell damage involved in modulation of reactive oxygen species and the mitogen-activated protein kinases. Int J Biochem Cell Biol. 39:426–438. 2007. View Article : Google Scholar : PubMed/NCBI
10	Hung JY, Yang CJ, Tsai YM, Huang HW and Huang MS: Antiproliferative activity of paeoniflorin is through cell cycle arrest and the Fas/Fas ligand-mediated apoptotic pathway in human non-small cell lung cancer A549 cells. Clin Exp Pharmacol Physiol. 35:141–147. 2008. View Article : Google Scholar : PubMed/NCBI
11	Hsu FL, Lai CW and Cheng JT: Antihyperglycemic effects of paeoniflorin and 8-debenzoylpaeoniflorin, glucosides from the root of Paeonia lactiflora. Planta Med. 63:323–325. 1997. View Article : Google Scholar : PubMed/NCBI
12	Zheng YQ, Wei W, Zhu L and Liu JX: Effects and mechanisms of Paeoniflorin, a bioactive glucoside from paeony root, on adjuvant arthritis in rats. Inflamm Res. 56:182–188. 2007. View Article : Google Scholar : PubMed/NCBI
13	Lee KP, Kim JE, Kim H, Chang HR, Lee DW and Park WH: Bo-Gan-Whan regulates proliferation and migration of vascular smooth muscle cells. BMC Complement Altern Med. 16:3062016. View Article : Google Scholar : PubMed/NCBI
14	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
15	Guo RB, Wang GF, Zhao AP, Gu J, Sun XL and Hu G: Paeoniflorin protects against ischemia-induced brain damages in rats via inhibiting MAPKs/NF-κB-mediated inflammatory responses. PLoS One. 7:e497012012. View Article : Google Scholar : PubMed/NCBI
16	Zheng YB, Xiao GC, Tong SL, Ding Y, Wang QS, Li SB and Hao ZN: Paeoniflorin inhibits human gastric carcinoma cell proliferation through up-regulation of microRNA-124 and suppression of PI3K/Akt and STAT3 signaling. World J Gastroenterol. 21:7197–7207. 2015. View Article : Google Scholar : PubMed/NCBI
17	Zhang Q, Yuan Y, Cui J, Xiao T and Jiang D: Paeoniflorin inhibits proliferation and invasion of breast cancer cells through suppressing Notch-1 signaling pathway. Biomed Pharmacother. 78:197–203. 2016. View Article : Google Scholar : PubMed/NCBI
18	Wu H, Li W, Wang T, Shu Y and Liu P: Paeoniflorin suppress NF-kappaB activation through modulation of I kappaB alpha and enhances 5-fluorouracil-induced apoptosis in human gastric carcinoma cells. Biomed Pharmacother. 62:659–666. 2008. View Article : Google Scholar : PubMed/NCBI
19	Jeong IK, Oh DH, Park SJ, Kang JH, Kim S, Lee MS, Kim MJ, Hwang YC, Ahn KJ, Chung HY, et al: Inhibition of NF-κB prevents high glucose-induced proliferation and plasminogen activator inhibitor-1 expression in vascular smooth muscle cells. Exp Mol Med. 43:684–692. 2011. View Article : Google Scholar : PubMed/NCBI
20	Cho A, Mitchell L, Koopmans D and Langille BL: Effects of changes in blood flow rate on cell death and cell proliferation in carotid arteries of immature rabbits. Circ Res. 81:328–337. 1997. View Article : Google Scholar : PubMed/NCBI
21	Lutgens E, de Muinck ED, Kitslaar PJ, Tordoir JH, Wellens HJ and Daemen MJ: Biphasic pattern of cell turnover characterizes the progression from fatty streaks to ruptured human atherosclerotic plaques. Cardiovasc Res. 41:473–479. 1999. View Article : Google Scholar : PubMed/NCBI
22	Ashino T, Yamamoto M and Numazawa S: Nrf2/Keap1 system regulates vascular smooth muscle cell apoptosis for vascular homeostasis: Role in neointimal formation after vascular injury. Sci Rep. 6:262912016. View Article : Google Scholar : PubMed/NCBI